We are a clinical stage research and development corporation focused on translating and delivering to market our proprietary and cutting edge life-saving CAR immunotherapies.
Giving Hope
Research conducted by iCell Gene Therapeutics has led to proprietary technologies and a pipeline of Chimeric Antigen Receptor (CAR) engineered cell therapies designed to be innovative, first in class, and life-saving.
Our development operations are focused on creative and efficient paths to bring novel, cost-effective therapies to patients. First mover clinical trials are ongoing in US & China, supported by our US research & development organization and a partnership with a state-of-the-art GMP facility in Zhongshan to manufacture precision-based therapeutics.